Literature DB >> 26515719

A simple method to overcome the inhibitory effect of heparin on DNA amplification.

P G Vaughan-Shaw1, M Walker2, L Ooi2, N Gilbert3, S M Farrington2, M G Dunlop2.   

Abstract

BACKGROUND: Genetic material from large patient cohorts is increasingly central to translational genetic research. However, patient blood samples are a finite resource and their supply and storage are often dictated by clinical and not research protocols. Our experience supports difficulty in amplifying DNA from blood stored in herparin; a scenario that other researchers may have or will encounter. This technical note describes a number of simple steps that enable successful PCR amplification.
METHODS: DNA was extracted using the Illustra Nucleon Genomic DNA Extraction Kit. PCR amplification was attempted using a number of commercially available PCR mastermixes.
RESULTS: PCR DNA amplification failed using ReddyMix™ PCR Master Mix, Thermo-Start® (Thermo Scientific Inc. US) and ZymoTaq™ (Zymo research, US) PCR mastermixes, as demonstrated absence of products on gel electrophoresis. However, using the Invitrogen™ (Thermo Scientific Inc., US) Platinum® Taq DNA Polymerase, PCR products were identified on a 1% agarose gel for all samples. PCR products were cleaned with ExoSAP-IT® (Affymetrix Inc., US) and a sequencing reaction undertaken using a standard Big Dye protocol. Subsequent genotyping was successful for all samples for alleles at the CDH1 locus.
CONCLUSION: From our experience a standard phenol/chloroform purification and using the Invitrogen™ Platinum® Taq has enabled the amplification of whole blood samples taken into lithium heparin and stored frozen for up to a month. This simple method may enable investigators to utilise blood taken in lithium heparin for DNA extraction and amplification.

Entities:  

Keywords:  Heparin; Polymerase chain reaction; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26515719      PMCID: PMC5860730          DOI: 10.1007/s13402-015-0250-8

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  5 in total

1.  Purification and characterization of PCR-inhibitory components in blood cells.

Authors:  W A Al-Soud; P Rådström
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Titration of heparinase for removal of the PCR-inhibitory effect of heparin in DNA samples.

Authors:  A C Taylor
Journal:  Mol Ecol       Date:  1997-04       Impact factor: 6.185

3.  Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood.

Authors:  S Izraeli; C Pfleiderer; T Lion
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

4.  Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay.

Authors:  M Willems; H Moshage; F Nevens; J Fevery; S H Yap
Journal:  J Virol Methods       Date:  1993-04       Impact factor: 2.014

5.  Effect of heparin on polymerase chain reaction.

Authors:  J Satsangi; D P Jewell; K Welsh; M Bunce; J I Bell
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

  5 in total
  3 in total

1.  Gene Expression Analysis of Endothelial Cells Exposed to Shear Stress Using Multiple Parallel-plate Flow Chambers.

Authors:  H S Jeffrey Man; Aravin N Sukumar; Kyung Ha Ku; Michelle K Dubinsky; Noeline Subramaniam; Philip A Marsden
Journal:  J Vis Exp       Date:  2018-10-21       Impact factor: 1.355

2.  PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.

Authors:  Clara Baldin; Sameh S M Soliman; Heewon H Jeon; Sondus Alkhazraji; Teclegiorgis Gebremariam; Yiyou Gu; Vincent M Bruno; Oliver A Cornely; Helen L Leather; Michele W Sugrue; John R Wingard; David A Stevens; John E Edwards; Ashraf S Ibrahim
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 3.  Extracellular Vesicles in Liquid Biopsies: Potential for Disease Diagnosis.

Authors:  Jialing Liu; Ye Chen; Fang Pei; Chongmai Zeng; Yang Yao; Wen Liao; Zhihe Zhao
Journal:  Biomed Res Int       Date:  2021-01-11       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.